Patients with fibromyalgia suffer from chronic pain, which limits physical activity and is associated with disturbed sleep. However, the relationship between physical activity, pain, and sleep is unclear.
To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.
Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.
Researchers sought to determine whether small-fiber pathology has any clinically important effect on somatosensory system function.
Researchers sought to evaluate the level of muscle tenderness and intramuscular pressure in the trapezius muscle of patients with fibromyalgia syndrome in comparison to controls.
Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Researchers compared the 3 diagnostic criteria and assessed the performance of an additional set of criteria in the diagnosis of fibromyalgia.
The FDA has expanded the approval of Cymbalta to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.
Researchers investigated the association of fibromyalgia and widespread pain with mortality.
